In New York, playing to voters’ concerns about crime has become a popular strategy, successful enough that even left-leaning Democrats have embraced calls for more police...
Even chatbots get the blues. According to a new study, OpenAI’s artificial intelligence tool ChatGPT shows signs of anxiety when its users share “traumatic narratives” about...
On a recent Friday morning, Daniel, a lawyer in his early 40s, was in a Zoom counseling session describing tapering off lithium. Earlier that week he...
Every day, Dora Dantzler-Wright and her colleagues distribute overdose reversal drugs on the streets of Chicago. They hold training sessions on using them and help people...
In November 2022, Justin Brannan, a city councilman who represents a big patch of South Brooklyn, was worrying about a woman who had been living in...
The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant schizophrenia, among...
It is a nightmare that plays out on the streets and subways every few months: A homeless person with a history of mental illness or violence...
Hospital and emergency room patients diagnosed with cannabis use disorder — defined as an inability to stop using cannabis even when the drug is causing harm...
After more than three decades of planning and a $250 million investment, Lykos Therapeutics’ application for the first psychedelic drug to reach federal regulators was expected...
A study of more than 30,000 British adults diagnosed with attention deficit hyperactivity disorder, or A.D.H.D., found that, on average, they were dying earlier than their...
